[ad_1] Mohit Bansal, a Wells Fargo analyst, stated that although the pace of deals in biotech is expected to increase, investors need to consider smaller
[ad_1] Traders have been laser-focused on profit-producing firms, which has left firms of their pre-revenue stage on the sidelines. Because of this, a rising variety
[ad_1] Potentially, investors are missing out on an opportunity: stocks in health-care companies. [ad_2]